Literature DB >> 12728410

Brain-derived neurotrophic factor, behavior, and new directions for the treatment of mental disorders.

Amelia Russo-Neustadt1.   

Abstract

Brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family of survival-promoting molecules, plays an important role in the growth, development, maintenance, and function of several neuronal systems. The purpose of this article is to point out evidence for the involvement of this molecule in the maintenance of normal cognitive and emotional functioning, and to outline recent developments using BDNF, or the regulation of endogenous BDNF expression, in the treatment of a variety of mental disorders. This article discusses the important role of BDNF in neuronal growth and survival, in modulating neurotransmission, in activity-directed synaptic remodeling, and in adult neurogenesis. We next outline evidence for the involvement of BDNF in complex behaviors such as learning, feeding, locomotion, responses to painful stimuli, and the management of severe stress. Finally, our review focuses on the involvement of BDNF in treatments for clinical depression and other chronic neurodegenerative processes. We discuss the way that current and future treatment development can be guided by our growing understanding of this molecule's actions in the brain and the ways the expression of BDNF can be regulated. Copyright 2003 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12728410     DOI: 10.1053/scnp.2003.50014

Source DB:  PubMed          Journal:  Semin Clin Neuropsychiatry        ISSN: 1084-3612


  25 in total

Review 1.  Neurotrophic mechanisms in drug addiction.

Authors:  Carlos A Bolaños; Eric J Nestler
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 2.  Development of neuropeptide drugs that cross the blood-brain barrier.

Authors:  Richard D Egleton; Thomas P Davis
Journal:  NeuroRx       Date:  2005-01

3.  Effects of sleep deprivation on behaviors and abnormal hippocampal BDNF/miR-10B expression in rats with chronic stress depression.

Authors:  Yuxue Jiang; Jinfu Zhu
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

4.  Levels of neurotrophic factors in the hippocampus and amygdala correlate with anxiety- and fear-related behaviour in C57BL6 mice.

Authors:  B K Yee; S-W Zhu; A H Mohammed; J Feldon
Journal:  J Neural Transm (Vienna)       Date:  2006-08-08       Impact factor: 3.575

5.  Association between Val66Met brain-derived neurotrophic factor (BDNF) gene polymorphism and post-treatment relapse in alcohol dependence.

Authors:  Marcin Wojnar; Kirk J Brower; Stephen Strobbe; Mark Ilgen; Halina Matsumoto; Izabela Nowosad; Elzbieta Sliwerska; Margit Burmeister
Journal:  Alcohol Clin Exp Res       Date:  2009-01-27       Impact factor: 3.455

Review 6.  Glutamate and neurotrophic factors in neuronal plasticity and disease.

Authors:  Mark P Mattson
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

7.  Insulin receptor substrate-2 in the ventral tegmental area regulates behavioral responses to cocaine.

Authors:  Sergio D Iñiguez; Brandon L Warren; Rachael L Neve; Eric J Nestler; Scott J Russo; Carlos A Bolaños-Guzmán
Journal:  Behav Neurosci       Date:  2008-10       Impact factor: 1.912

8.  Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.

Authors:  Marwa Aboukhatwa; Laura Dosanjh; Yuan Luo
Journal:  Mol Neurodegener       Date:  2010-03-12       Impact factor: 14.195

9.  The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model.

Authors:  Qi Peng; Naoki Masuda; Mali Jiang; Qing Li; Ming Zhao; Christopher A Ross; Wenzhen Duan
Journal:  Exp Neurol       Date:  2007-11-09       Impact factor: 5.330

10.  Cognitive impairment in elderly women: the relative importance of selected genes, lifestyle factors, and comorbidities.

Authors:  Henrik Berg Rasmussen; Yu Z Bagger; László B Tankó; Gerong Qin; Claus Christiansen; Thomas Werge
Journal:  Neuropsychiatr Dis Treat       Date:  2006-06       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.